CVR Medical Corp.
CRRVF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.00 | 0.03 | -0.00 |
| FCF Yield | -39.60% | -220.02% | -3.44% | -1.52% |
| EV / EBITDA | -5.48 | -7.76 | -19.96 | -2.96 |
| Quality | ||||
| ROIC | 2.79% | 2.82% | 3.76% | 5.74% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.66 | 0.49 | 0.39 | 0.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | -81.31% | -78.56% | -2.22% | 8.85% |
| Safety | ||||
| Net Debt / EBITDA | -3.67 | -7.37 | -6.81 | -0.50 |
| Interest Coverage | -5.18 | -5.57 | -7.45 | -11.22 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |